BioSpace News Archive

The U.S. Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels.

The Modern Healthcare 2019 annual report again named B.E. Smith as the top healthcare executive search firm based on the total number of candidate placements throughout 2018. B.E. Smith has been ranked as the industry’s largest search firm in eight out of the past 11 years.

Gemini Therapeutics, a precision medicine company developing innovative treatments for age-related macular degeneration (AMD) and linked ocular disorders, today announced the appointment of Jason Meyenburg, MBA, as Chief Executive Officer (CEO).

Zeta Phi Beta Sorority, Inc., an international women’s service organization and 47-year partner with the March of Dimes, was recognized by March of Dimes president, Stacey Stewart, for winning the “March of Dimes Gwen Carmen Alpha Phi Alpha/Zeta Phi Beta Challenge Award” on Sept. 10 at a reception held at the sorority’s headquarters in Washington D.C

Academic medical center’s leading-edge technology and superior design will provide patients and families with world-class acute care

DDS Lab will offer Keystone Dental participating dentists exceptional quality, service and value on dental laboratory implants, products and services.

Glycosyn LLC Wins Significant Initial Determination Against Jennewein Biotechnologie GmbH

Induction of Antigen-Specific Immune Tolerance Using Proprietary Technology Represents Novel, Targeted Treatment Modality for Autoimmune Diseases

Retrospective Findings Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 24th Annual Conference of Rehabilitation in Multiple Sclerosis

Gossamer Bio, Inc. announced Otello Stampacchia, Ph.D., of Omega Funds, resigned from the company’s Board of Directors.